MEGAN HENDERSON: Open Payments
NPI 1447816921 · DENVER, CO. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$560 in 24 payments from 14 companies in 2025. Trend: 2023 $376 · 2024 $296 · 2025 $560
Food & beverage: $560
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 2 | $69 |
| SOBI, INC | 3 | $67 |
| ABBVIE INC. | 3 | $58 |
| Syndax Pharmaceuticals, Inc. | 2 | $51 |
| Merck Sharp & Dohme LLC | 2 | $49 |
| Incyte Corporation | 2 | $47 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| JAZZ PHARMACEUTICALS INC. | 1 | $34 |
| PFIZER INC. | 2 | $32 |
| Celgene Corporation | 1 | $28 |
Products named: Vonjo, REVUFORJ, TheraSphere Y90 Glass Microspheres 10 GBq, ICLUSIG, IMBRUVICA, RYLAZE, ELREXFIO, REBLOZYL.
Industry payments across CO — which companies pay providers there.
